Skip to main content
Clinical Trials/NCT03569306
NCT03569306
Unknown
Not Applicable

Electromagnetic Navigation Bronchoscopy in the Diagnosis of Peripheral Pulmonary Nodules

Shanghai Chest Hospital1 site in 1 country400 target enrollmentJuly 4, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Pulmonary Nodules
Sponsor
Shanghai Chest Hospital
Enrollment
400
Locations
1
Primary Endpoint
The difference of diagnostic yield between ENB-EBUS-GS group and EBUS-GS group
Last Updated
7 years ago

Overview

Brief Summary

The study is designed as a multi-center prospective trial with two arms, ENB-EBUS-GS group and EBUS-GS group, and aimed to evaluate the diagnostic yield and operation time between the two groups.

Detailed Description

The study is designed as a multi-center prospective trial with two arms, ENB-EBUS-GS group and EBUS-GS group, and aimed to evaluate the diagnostic yield and operation time between the two groups. Patients with peripheral pulmonary nodules that need to be confirmed by pathology will be enrolled in the study. A total of 400 patients are expected to be enrolled. EBUS will be used in both group. Biopsy, brushing and washing will be performed when EBUS image present. Brushing, washing and lavage will be performed when EBUS image absent.

Registry
clinicaltrials.gov
Start Date
July 4, 2018
End Date
December 30, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jiayuan Sun

Director, Department of Endoscopy

Shanghai Chest Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who are older than 18 year-old.
  • Chest CT shows peripheral pulmonary nodule (8mm\<longest diameter≤30mm) suspected to be malignant that need to be confirmed by pathology. The nodule is surrounded by lung parenchyma and invisible in standard bronchoscopy.
  • Patients who agree to undergo bronchoscopy without any contraindications.
  • Patients who have good compliance and sign informed consent.

Exclusion Criteria

  • Chest CT scan shows that the pulmonary nodule is pure ground glass opacity.
  • Presence of concomitant endobronchial lesion during the brochoscopy procerdure.
  • Severe cardiopulmonary dysfunction and other indications that can't receive bronchoscopy.

Outcomes

Primary Outcomes

The difference of diagnostic yield between ENB-EBUS-GS group and EBUS-GS group

Time Frame: one year

Diagnostic yield is defined as proportion of true positive and true negative.

Secondary Outcomes

  • The difference of operation time between ENB-EBUS-GS group and EBUS-GS group(one week)
  • The difference of complications between ENB-EBUS-GS group and EBUS-GS group(three months)

Study Sites (1)

Loading locations...

Similar Trials